Opsidio, LLC
Biotechnology company · Bryn Mawr, Pennsylvania, United States
Opsidio, LLC is a biotechnology company headquartered in Bryn Mawr, Pennsylvania, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $217,446 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $800,165 sold in a notice filed in 2017.
Opsidio at a glance
What does Opsidio do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $217,446 in total (2017). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $800,165 sold (2017).
Frequently asked questions about Opsidio
Where is Opsidio headquartered?
Opsidio, LLC is headquartered in Bryn Mawr, Pennsylvania, United States.
What does Opsidio do?
Opsidio, LLC is a biotechnology company.
Similar companies
- AlphatheraBryn Mawr, Pennsylvania, United States
- Lenima Field Diagnostics LLCBryn Mawr, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences